Ann: Trading Halt, page-105

First 105 Last

Share
Profile

Follow
Merchant2000

24,965 Posts.

984

13/12/24

16:30

Post #: 77040461
Share

Originally posted by chuk: ↑

I'd also have preferred no options, EXCEPT;
I suspect a lot of large holders may have bought a lot of stock on the last cr at 7c, more at 6c, 5c and down to 4c. I know I did and I know many others that did the same (large and small holders).
Without the options, why would there be incentive for those shareholders to buy now at 7c when they either bought or had the opportunity to buy at down to 4c so recently?
I participated in this cr, but because I did significantly increase my holdings well below 7c already, I only participated because the options were offered. I suspect they would have had a hard time raising anything much at all without the options thrown in if most potential cr participants were already overweight from buying below 7c.
They needed some extra cash now so did what was needed to keep this project progressing.
The best thing for all shareholders is that the project moves forward and doesn't stall again. This is only a small raise and not too dilutive.
No existing shareholder likes cr's but they are needed from time to time. Now was one of those times.

Expand

$6m will barely last the next quarter

@chuk have a good weekend

Dilution after Dilution - mates rates

Select Few $$$$$$$$$$$$$$

Thanks for the potential 7c pick ups next week before the next pump

2 Billion SOI is where this is headed in Full African Control

IMO

Last edited by Merchant2000: 13/12/24

MNB Price at posting: 8.5¢ Sentiment: Hold Disclosure: Not Held
Upvote

0 Great analysis

Reply

Top Stories

Expert Exchange: It's half time Down Under – How are we faring?

BPH

Australia’s gas crisis is here – and dying coal plants aren’t helping

NMT

Neometals-MinRes JV inks MOU with Rio Tinto on lithium electrolysis

PAR

Paradigm adds new oral combo IP to osteoarthritis drug stable with $500K pick-up

NEU

Neuren jumps over +11% on patent win for Pitt Hopkins drug treatment

First 105 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 4.0¢		Change 0.003(8.11%)		Mkt cap ! $39.00M

Open	High	Low	Value	Volume
3.8¢	4.0¢	3.8¢	$11.72K	298.3K

Buyers (Bids)

No.	Vol.	Price($)
1	119438	4.0¢

Sellers (Offers)

Price($)	Vol.	No.
4.1¢	30000	2

View Market Depth

No.	Vol.	Price($)
1	119438	0.040
2	53000	0.039
8	299059	0.037
3	498360	0.036
8	742117	0.035

Price($)	Vol.	No.
0.041	30000	2
0.042	150000	2
0.044	46000	1
0.045	118300	2
0.048	497000	2

Last trade - 11.46am 26/06/2025 (20 minute delay)

MNB (ASX) Chart

Ann: Trading Halt, page-105

Expert Exchange: It's half time Down Under – How are we faring?

Australia’s gas crisis is here – and dying coal plants aren’t helping

Neometals-MinRes JV inks MOU with Rio Tinto on lithium electrolysis

Paradigm adds new oral combo IP to osteoarthritis drug stable with $500K pick-up

Neuren jumps over +11% on patent win for Pitt Hopkins drug treatment

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: Trading Halt, page-105

Top Stories

Expert Exchange: It's half time Down Under – How are we faring?

Australia’s gas crisis is here – and dying coal plants aren’t helping

Neometals-MinRes JV inks MOU with Rio Tinto on lithium electrolysis

Paradigm adds new oral combo IP to osteoarthritis drug stable with $500K pick-up

Neuren jumps over +11% on patent win for Pitt Hopkins drug treatment

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News